Ferulic acid methyl ester(Synonyms: 阿魏酸甲酯; Methyl ferulate)

发表于2024年4月13日由上海金畔生物科技有限公司

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

Ferulic acid methyl ester (Synonyms: 阿魏酸甲酯; Methyl ferulate) 纯度: 99.93%

Ferulic acid methyl ester (Methyl ferulate) 是从 Stemona tuberosa 中分到的阿魏酸衍生物，具有抗氧化、抗炎作用。Ferulic acid methyl ester 能够透过细胞膜和血脑屏障，清除自由基，可用于神经退行性疾病的研究。在原发性骨髓源性巨噬细胞中，Ferulic acid methyl ester 抑制 COX-2 的表达，降低 p-p38 和 p-JNK 的水平。

Ferulic acid methyl ester Chemical Structure

CAS No. : 2309-07-1

规格	价格	是否有货
Free Sample (0.1-0.5 mg)		Apply now
10 mM * 1 mL in DMSO	￥550	In-stock
100 mg	￥500	In-stock
200 mg		询价
500 mg		询价

* Please select Quantity before adding items.

Ferulic acid methyl ester 相关产品

•相关化合物库:

Natural Product Library Plus
Bioactive Compound Library Plus
Immunology/Inflammation Compound Library
Kinase Inhibitor Library
MAPK Compound Library
Natural Product Library
Anti-Cancer Compound Library
CNS-Penetrant Compound Library
Autophagy Compound Library
Reprogramming Compound Library
Oxygen Sensing Compound Library
Phenols Library
Pyroptosis Compound Library
Anti-Lung Cancer Compound Library
Neurodegenerative Disease-related Compound Library
Angiogenesis Related Compound Library
Food-Sourced Compound Library

生物活性

Ferulic acid methyl ester (Methyl ferulate) is a derivative of ferulic acid, isolated from Stemona tuberosa, with anti-inflammatory and antioxidant properties^[1]^[2]. Ferulic acid methyl ester is a cell membrane and brain permeable compound, shows free radical scavenging ability, used in the research of neurodegenerative disorders^[1]. Ferulic acid methyl ester inhibits COX-2 expression, blocks p-p38 and p-JNK in primary bone marrow derived-macrophages^[2].

IC₅₀ & Target^[2]

p38

体外研究
(In Vitro)

Ferulic acid methyl ester (25 µg/mL) has no cytotoxic effects on BMDMs after treatment for 6 h, 18 h, 48 h^[2].
Ferulic acid methyl ester (Methyl ferulate; 5, 10, 25 µg/mL) suppresses TNFα, IL6, IFNγ but not IL10, inhibits NO generation at 10 and 25 µg/mL, in primary bone marrow derived-macrophages (BMDMs)^[2].
Ferulic acid methyl ester (25 µg/mL) inhibits COX-2 expression, blocks p-p38 and p-JNK^[2].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[2]

Cell Line:	Primary bone marrow derived-macrophages (BMDMs)
Concentration:	25 µg/mL
Incubation Time:	6 h, 18 h, 48 h
Result:	Showed no cytotoxic effects on BMDMs.

Western Blot Analysis^[2]

Cell Line:	RAW 246.7 cells
Concentration:	10 µg/mL and 25 µg/mL
Incubation Time:	For 1 h before stimulation with LPS
Result:	Significantly suppressed COX-2 expression at 25 µg/mL.

分子量

208.21

Formula

C₁₁H₁₂O₄

CAS 号

2309-07-1

中文名称

阿魏酸甲酯

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

溶解性数据

In Vitro:

DMSO : ≥ 100 mg/mL (480.28 mM)

H₂O : 2 mg/mL (9.61 mM; Need ultrasonic)

* “≥” means soluble, but saturation unknown.

配制储备液

浓度溶剂体积质量	1 mg	5 mg	10 mg

1 mM	4.8028 mL	24.0142 mL	48.0284 mL
5 mM	0.9606 mL	4.8028 mL	9.6057 mL
10 mM	0.4803 mL	2.4014 mL	4.8028 mL

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month。-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液，再依次添加助溶剂：

——为保证实验结果的可靠性，澄清的储备液可以根据储存条件，适当保存；体内实验的工作液，建议您现用现配，当天使用；以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比；如在配制过程中出现沉淀、析出现象，可以通过加热和/或超声的方式助溶

1.

请依序添加每种溶剂： 10% DMSO 40% PEG300 5% Tween-80 45% saline

Solubility: ≥ 2.5 mg/mL (12.01 mM); Clear solution

此方案可获得 ≥ 2.5 mg/mL (12.01 mM，饱和度未知) 的澄清溶液。

以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中，混合均匀；向上述体系中加入50 μL Tween-80，混合均匀；然后继续加入 450 μL生理盐水定容至 1 mL。

将 0.9 g 氯化钠，完全溶解于 100 mL ddH₂O 中，得到澄清透明的生理盐水溶液
2.

请依序添加每种溶剂： 10% DMSO 90% (20% SBE-β-CD in saline)

Solubility: ≥ 2.5 mg/mL (12.01 mM); Clear solution

此方案可获得 ≥ 2.5 mg/mL (12.01 mM，饱和度未知) 的澄清溶液。

以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中，混合均匀。

将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中，再用生理盐水定容至 10 mL，完全溶解，澄清透明
3.

请依序添加每种溶剂： 10% DMSO 90% corn oil

Solubility: ≥ 2.5 mg/mL (12.01 mM); Clear solution

此方案可获得 ≥ 2.5 mg/mL (12.01 mM，饱和度未知) 的澄清溶液，此方案不适用于实验周期在半个月以上的实验。

以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中，混合均匀。

*以上所有助溶剂都可在上海金畔生物科技有限公司网站选购。

参考文献

[1]. Sultana R. Ferulic acid ethyl ester as a potential therapy in neurodegenerative disorders. Biochim Biophys Acta. 2012 May;1822(5):748-52.

[2]. Phuong NT, et al. Anti-inflammatory activity of methyl ferulate isolated from Stemona tuberosa Lour. Asian Pac J Trop Med. 2014 Sep;7S1:S327-31.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

(E)-Ferulic acid(Synonyms: (E)-Coniferic acid)

发表于2024年4月13日由上海金畔生物科技有限公司

(E)-Ferulic acid (Synonyms: (E)-Coniferic acid) 纯度: 99.20%

(E)-Ferulic acid 是阿魏酸 (Ferulic acid) 的异构体，阿魏酸是芳香族化合物，在植物细胞壁中丰富。 (E)-Ferulic acid 引起 β-连环蛋白 (β-catenin) 的磷酸化，导致蛋白酶体降解，增加促凋亡因子 Bax 的表达并降低促存活因子存活蛋白的表达。(E)-Ferulic acid 可以有效去除活性氧 (ROS) 和抑制脂质过氧化。(E)-Ferulic acid 在人肺癌细胞系 H1299 中发挥抗增殖和抗迁移作用。

(E)-Ferulic acid Chemical Structure

CAS No. : 537-98-4

规格	价格	是否有货
Free Sample (0.1-0.5 mg)		Apply now
10 mM * 1 mL in DMSO	￥550	In-stock
100 mg	￥500	In-stock
200 mg		询价
500 mg		询价

* Please select Quantity before adding items.

(E)-Ferulic acid 相关产品

•相关化合物库:

Natural Product Library Plus
Bioactive Compound Library Plus
Apoptosis Compound Library
Metabolism/Protease Compound Library
Stem Cell Signaling Compound Library
Wnt/Hedgehog/Notch Compound Library
Natural Product Library
Anti-Cancer Compound Library
Human Endogenous Metabolite Compound Library
Anti-Aging Compound Library
Reprogramming Compound Library
Ferroptosis Compound Library
Phenols Library
Cytoskeleton Compound Library
Traditional Chinese Medicine Monomer Library
Neuroprotective Compound Library
Anti-Lung Cancer Compound Library
Microbial Metabolite Library
Anti-Obesity Compound Library
Transcription Factor Targeted Library
Food-Sourced Compound Library

生物活性

(E)-Ferulic acid is a isomer of Ferulic acid which is an aromatic compound, abundant in plant cell walls. (E)-Ferulic acid causes the phosphorylation of β-catenin, resulting in proteasomal degradation of β-catenin and increases the expression of pro-apoptotic factor Bax and decreases the expression of pro-survival factor survivin. (E)-Ferulic acid shows a potent ability to remove reactive oxygen species (ROS) and inhibits lipid peroxidation. (E)-Ferulic acid exerts both anti-proliferation and anti-migration effects in the human lung cancer cell line H1299^[1].

IC₅₀ & Target

Bax	Human Endogenous Metabolite

分子量

194.18

Formula

C₁₀H₁₀O₄

CAS 号

537-98-4

中文名称

反式-阿魏酸

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

溶解性数据

In Vitro:

DMSO : 100 mg/mL (514.99 mM; Need ultrasonic)

配制储备液

浓度溶剂体积质量	1 mg	5 mg	10 mg

1 mM	5.1499 mL	25.7493 mL	51.4986 mL
5 mM	1.0300 mL	5.1499 mL	10.2997 mL
10 mM	0.5150 mL	2.5749 mL	5.1499 mL

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液，再依次添加助溶剂：

1.

请依序添加每种溶剂： 10% DMSO 40% PEG300 5% Tween-80 45% saline

Solubility: ≥ 2.5 mg/mL (12.87 mM); Clear solution

此方案可获得 ≥ 2.5 mg/mL (12.87 mM，饱和度未知) 的澄清溶液。

以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中，混合均匀；向上述体系中加入50 μL Tween-80，混合均匀；然后继续加入 450 μL生理盐水定容至 1 mL。

将 0.9 g 氯化钠，完全溶解于 100 mL ddH₂O 中，得到澄清透明的生理盐水溶液
2.

请依序添加每种溶剂： 10% DMSO 90% (20% SBE-β-CD in saline)

Solubility: ≥ 2.5 mg/mL (12.87 mM); Clear solution

此方案可获得 ≥ 2.5 mg/mL (12.87 mM，饱和度未知) 的澄清溶液。

以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中，混合均匀。

将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中，再用生理盐水定容至 10 mL，完全溶解，澄清透明
3.

请依序添加每种溶剂： 10% DMSO 90% corn oil

Solubility: ≥ 2.5 mg/mL (12.87 mM); Clear solution

此方案可获得 ≥ 2.5 mg/mL (12.87 mM，饱和度未知) 的澄清溶液，此方案不适用于实验周期在半个月以上的实验。

以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中，混合均匀。

*以上所有助溶剂都可在上海金畔生物科技有限公司网站选购。

参考文献

[1]. Fong Y, et al. Inhibitory effect of trans-ferulic acid on proliferation and migration of human lung cancer cells accompanied with increased endogenous reactive oxygen species and β-catenin instability. Chin Med. 2016 Oct 1;11:45.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

Tolfenamic Acid-D4(Synonyms: 托芬那酸 D4)

发表于2024年4月12日由上海金畔生物科技有限公司

Tolfenamic Acid-D4 (Synonyms: 托芬那酸 D4)

Tolfenamic Acid-D4 (GEA 6414-D4) 是 Tolfenamic Acid 的氘代物。Tolfenamic Acid (GEA 6414) 是一种非甾体抗炎剂和抗癌剂，能够选择性地抑制 COX-2 的活性，在 LPS 诱导的犬 DH82 单核细胞/巨噬细胞中，对 COX-2 的 IC₅₀ 值为 13.49 μM (3.53 μg/mL)，对 COX-1 无作用。

Tolfenamic Acid-D4 Chemical Structure

CAS No. : 1246820-82-5

规格		是否有货
100 mg		询价
250 mg		询价
500 mg		询价

* Please select Quantity before adding items.

生物活性	Tolfenamic Acid-D4 (GEA 6414-D4) is the deuterium labeled Tolfenamic Acid. Tolfenamic Acid (GEA 6414) is a non-steroidal anti-inflammatory and anti-cancer agent, selectively inhibits COX-2, with an IC₅₀ of 13.49 μM (3.53 μg/mL) in LPS-treated (COX-2) canine DH82 monocyte/macrophage cells, but shows no effect on COX-1^[1]^[2].
体外研究 (In Vitro)	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs^[1]. Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
分子量	265.73
Formula	C₁₄H₈D₄ClNO₂
CAS 号	1246820-82-5
中文名称	托芬那酸 D4
运输条件	Room temperature in continental US; may vary elsewhere.
储存方式	Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Kay-Mugford P, et al. In vitro effects of nonsteroidal anti-inflammatory drugs on cyclooxygenase activity in dogs. Am J Vet Res. 2000 Jul;61(7):802-10. [3]. Maliakal P, et al. Chemopreventive effects of tolfenamic acid against esophageal tumorigenesis in rats. Invest New Drugs. 2012 Jun;30(3):853-61. [4]. Sankpal UT, et al. Tolfenamic acid-induced alterations in genes and pathways in pancreatic cancer cells. Oncotarget. 2017 Feb 28;8(9):14593-14603

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

Embelin(Synonyms: 恩贝酸; Embelic acid; Emberine; NSC 91874)

发表于2024年4月12日由上海金畔生物科技有限公司

Embelin (Synonyms: 恩贝酸; Embelic acid; Emberine; NSC 91874) 纯度: 98.75%

Embelin (Embelic acid) 是一种有效的、非肽类的细胞渗透性 XIAP 抑制剂 (IC₅₀=4.1 μM)，在高水平 XIAP 的前列腺癌细胞中抑制细胞生长，诱导凋亡 (apoptosis)，并激活 caspase-9。Embelin 阻断 NF-kappaB 信号通路，从而抑制 NF-kappaB 调节的抗凋亡和转移基因产物。Embelin 诱导口腔鳞癌细胞自噬和凋亡。

Embelin Chemical Structure

CAS No. : 550-24-3

规格	价格	是否有货
10 mM * 1 mL in DMSO	￥563	In-stock
10 mg	￥512	In-stock
50 mg	￥2000	In-stock
100 mg		询价
200 mg		询价

* Please select Quantity before adding items.

Embelin 相关产品

•相关化合物库:

Natural Product Library Plus
FDA-Approved Drug Library Mini
Bioactive Compound Library Plus
Apoptosis Compound Library
Immunology/Inflammation Compound Library
NF-κB Signaling Compound Library
Stem Cell Signaling Compound Library
Natural Product Library
Anti-Cancer Compound Library
Autophagy Compound Library
Anti-Aging Compound Library
Antioxidants Compound Library
Differentiation Inducing Compound Library
Oxygen Sensing Compound Library
Pyroptosis Compound Library
Traditional Chinese Medicine Monomer Library
Anti-Breast Cancer Compound Library
Anti-Pancreatic Cancer Compound Library
Anti-Blood Cancer Compound Library
Anti-Obesity Compound Library
Transcription Factor Targeted Library
Targeted Diversity Library
Anti-Liver Cancer Compound Library

生物活性

Embelin (Embelic acid), a potent, nonpeptidic XIAP inhibitor (IC₅₀=4.1 μM), inhibits cell growth, induces apoptosis, and activates caspase-9 in prostate cancer cells with high levels of XIAP. Embelin blocks NF-kappaB signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products. Embelin also induces autophagic and apoptotic cell death in human oral squamous cell carcinoma cells^[1]^[2]^[3].

IC₅₀ & Target^[1]

XIAP

4.1 μM (IC₅₀)

体外研究
(In Vitro)

Embelin (Embelic acid) has a minimal effect on normal prostate epithelial and fibroblast cells with low levels of XIAP^[1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

294.39

Formula

C₁₇H₂₆O₄

CAS 号

550-24-3

中文名称

恩贝酸；恩贝灵；信筒子醌

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

溶解性数据

In Vitro:

DMSO : ≥ 50 mg/mL (169.84 mM)

* “≥” means soluble, but saturation unknown.

配制储备液

浓度溶剂体积质量	1 mg	5 mg	10 mg

1 mM	3.3969 mL	16.9843 mL	33.9685 mL
5 mM	0.6794 mL	3.3969 mL	6.7937 mL
10 mM	0.3397 mL	1.6984 mL	3.3969 mL

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液，再依次添加助溶剂：

1.

请依序添加每种溶剂： 10% DMSO 40% PEG300 5% Tween-80 45% saline

Solubility: 2.5 mg/mL (8.49 mM); Suspended solution; Need ultrasonic

此方案可获得 2.5 mg/mL (8.49 mM) 的均匀悬浊液，悬浊液可用于口服和腹腔注射。

以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中，混合均匀；向上述体系中加入50 μL Tween-80，混合均匀；然后继续加入 450 μL生理盐水定容至 1 mL。

将 0.9 g 氯化钠，完全溶解于 100 mL ddH₂O 中，得到澄清透明的生理盐水溶液
2.

请依序添加每种溶剂： 10% DMSO 90% corn oil

Solubility: ≥ 2.5 mg/mL (8.49 mM); Clear solution

此方案可获得 ≥ 2.5 mg/mL (8.49 mM，饱和度未知) 的澄清溶液，此方案不适用于实验周期在半个月以上的实验。

以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中，混合均匀。

*以上所有助溶剂都可在上海金畔生物科技有限公司网站选购。

参考文献

[1]. Nikolovska-Coleska Z, et al. Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database. J Med Chem. 2004;47(10):2430-2440.

[2]. Ahn KS, et al. Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products. Mol Pharmacol. 2007;71(1):209-219.

[3]. Lee YJ, et al. XIAP inhibitor embelin induces autophagic and apoptotic cell death in human oral squamous cell carcinoma cells. Environ Toxicol. 2017;32(11):2371-2378.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

5-Hydroxyindole-3-acetic acid-d2

发表于2024年4月12日由上海金畔生物科技有限公司

5-Hydroxyindole-3-acetic acid-d2

5-Hydroxyindole-3-acetic acid-d2 是 5-Hydroxyindole-3-acetic acid 的氘代物。5-Hydroxyindole-3-acetic acid 是 5-羟色胺或甲氧基肾上腺素的主要代谢产物，被用作神经内分泌肿瘤的生物标志物。

5-Hydroxyindole-3-acetic acid-d2 Chemical Structure

CAS No. : 56209-31-5

规格		是否有货
1 mg		Check price and availability
5 mg		Check price and availability
10 mg		Check price and availability
25 mg		Check price and availability

* Please select Quantity before adding items.

生物活性	5-Hydroxyindole-3-acetic acid-d2 is the deuterium labeled 5-Hydroxyindole-3-acetic acid. 5-Hydroxyindole-3-acetic acid is the main metabolite of serotonin or metanephrines, which can be used as a biomarker of neuroendocrine tumors.
体外研究 (In Vitro)	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs^[1]. Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
分子量	193.20
Formula	C₁₀H₇D₂NO₃
CAS 号	56209-31-5
运输条件	Room temperature in continental US; may vary elsewhere.
储存方式	Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Corcuff JB, et al. Urinary sampling for 5HIAA and metanephrines determination: revisiting the recommendations. Endocr Connect. 2017 Aug;6(6):R87-R98.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

Lipoic acid PEG azide, LA-PEG-N3 Cat. No. PG2-AZLA-5k 5000 Da 100 mg修饰性聚乙二醇

发表于2024年4月12日由上海金畔生物科技有限公司

上海金畔生物科技有限公司提供各种分子量和基团修饰性聚乙二醇定制服务。

Lipoic acid PEG azide, LA-PEG-N3

Cat. No.	PG2-AZLA-5k
Specification	5000 Da
Unit Size	100 mg
Price	$385.00

Description:

Lipoic acid PEG azide is one of Nanocs’ surface reactive PEG derivatives that have a lipoic acid moiety on one PEG terminus and an azide group on the other PEG end. Lipoic acid, also known as thioctic acid, is an important bioactive molecule participating in various biological processes. PEG functionalized lipoic acid can be used to bind to metallic particle or film surface with its disulfide bond. Lipoic acid group has high affinity to metallic surfaces and have been widely used for gold nanoparticles and quantum dots surface modification. Azide group can react with linear alkye or strain-promoted cyclooctyne through so called Click Chemistry. PEGylated lipoic acid azide is water soluble and can be used directly in aqueous buffer.

Physical Properties:

Off-yellow solid.
Soluble in regular aqeous solution as well as most organic solvents;
Reactive group: Azide (-N3):
Reactive toward: Alkyne;

Storage Conditions:

Store at -20 ⁰C.

Documents

SDS
DataSheet

18α-Glycyrrhetinic acid(Synonyms: 18-α-甘草次酸)

发表于2024年4月12日由上海金畔生物科技有限公司

18α-Glycyrrhetinic acid (Synonyms: 18-α-甘草次酸) 纯度: 95.40%

18α-Glycyrrhetinic acid，一种饮食衍生的化合物，是 NF-kB 的抑制剂和蛋白酶体 (proteasome) 的激活剂，在多细胞生物中起到促进长寿和抗聚集因子的作用。18α-Glycyrrhetinic acid 诱导细胞凋亡。

18α-Glycyrrhetinic acid Chemical Structure

CAS No. : 1449-05-4

规格	价格	是否有货
25 mg	￥900	In-stock
100 mg	￥2400	In-stock
500 mg	￥6000	In-stock
1 g		询价
5 g		询价

* Please select Quantity before adding items.

18α-Glycyrrhetinic acid 相关产品

•相关化合物库:

Natural Product Library Plus
Drug Repurposing Compound Library Plus
FDA-Approved Drug Library Plus
Bioactive Compound Library Plus
Apoptosis Compound Library
Immunology/Inflammation Compound Library
Metabolism/Protease Compound Library
NF-κB Signaling Compound Library
Stem Cell Signaling Compound Library
Natural Product Library
FDA-Approved Drug Library
Anti-Cancer Compound Library
Anti-Aging Compound Library
Drug Repurposing Compound Library
Antioxidants Compound Library
Differentiation Inducing Compound Library
Lipid Compound Library
Oxygen Sensing Compound Library
Ubiquitination Compound Library
NMPA-Approved Drug Library
Medicine Food Homology Compound Library
Terpenoids Library
Pyroptosis Compound Library
Traditional Chinese Medicine Monomer Library
FDA Approved & Pharmacopeial Drug Library
Anti-Breast Cancer Compound Library
Anti-Pancreatic Cancer Compound Library
Anti-Blood Cancer Compound Library
Anti-Obesity Compound Library
Transcription Factor Targeted Library
Food-Sourced Compound Library
Anti-Liver Cancer Compound Library

生物活性

18α-Glycyrrhetinic acid, a diet-derived compound, is an inhibitor of NF-kB and an activator of proteasome, which serves as pro-longevity and anti-aggregation factor in a multicellular organism. 18α-Glycyrrhetinic acid induces apoptosis^[1]^[2].

IC₅₀ & Target^[1]^[2]

NF-κB

Proteasome

体外研究
(In Vitro)

18α-Glycyrrhetinic acid (18a-GA) markedly reduces LX-2 cell numbers by 14.8% and 31.2% after 48 h and 72 h of treatment, respectively (P< 0.05). 18α-Glycyrrhetinic acid also significantly increases the percentage of LX-2 cells in phase G0/G1 and decreases it in phase S after treated for 48 h and 72 h compare with the control group. 18α-Glycyrrhetinic acid increases apoptosis to 6.8% at 48 h, compare with control (2.5%), and at 72 h the percentages of apoptotic cells in control and the treatment groups are 3.1% and 15.6%, respectively, in LX-2 cells (P<0.01). Furthermore, 18α-Glycyrrhetinic acid induces expression of PPAR-γ and alters some cell cycle and apoptosis-related proteins. 18α-Glycyrrhetinic acid also inhibits NF-κB DNA-binding activity^[1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

18α-Glycyrrhetinic acid (18α-GA) treatment significantly enhances life span of C. elegans strains with the most effective concentration being 20 μg/mL. Results reveal a significant delay of paralysis upon 18α-Glycyrrhetinic acid treatment. 18α-Glycyrrhetinic acid treatment also confers a significant reduction of Aβ deposits^[2].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

470.68

Formula

C₃₀H₄₆O₄

CAS 号

1449-05-4

中文名称

18-α-甘草次酸

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

溶解性数据

In Vitro:

DMSO : 19.23 mg/mL (40.86 mM; Need ultrasonic)

配制储备液

浓度溶剂体积质量	1 mg	5 mg	10 mg

1 mM	2.1246 mL	10.6229 mL	21.2459 mL
5 mM	0.4249 mL	2.1246 mL	4.2492 mL
10 mM	0.2125 mL	1.0623 mL	2.1246 mL

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液，再依次添加助溶剂：

1.

请依序添加每种溶剂： 10% DMSO 40% PEG300 5% Tween-80 45% saline

Solubility: 1.92 mg/mL (4.08 mM); Suspended solution; Need ultrasonic

此方案可获得 1.92 mg/mL (4.08 mM) 的均匀悬浊液，悬浊液可用于口服和腹腔注射。

以 1 mL 工作液为例，取 100 μL 19.2 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中，混合均匀；向上述体系中加入50 μL Tween-80，混合均匀；然后继续加入 450 μL生理盐水定容至 1 mL。

将 0.9 g 氯化钠，完全溶解于 100 mL ddH₂O 中，得到澄清透明的生理盐水溶液
2.

请依序添加每种溶剂： 10% DMSO 90% corn oil

Solubility: ≥ 1.92 mg/mL (4.08 mM); Clear solution

此方案可获得 ≥ 1.92 mg/mL (4.08 mM，饱和度未知) 的澄清溶液，此方案不适用于实验周期在半个月以上的实验。

以 1 mL 工作液为例，取 100 μL 19.2 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中，混合均匀。

*以上所有助溶剂都可在上海金畔生物科技有限公司网站选购。

参考文献

[1]. Zong L et al. 18α-glycyrrhetinic acid extracted from Glycyrrhiza radix inhibits proliferation and promotes apoptosis of the hepatic stellate cell line. J Dig Dis. 2013 Jun;14(6):328-36.

[2]. Papaevgeniou N, et al. 18α-Glycyrrhetinic Acid Proteasome Activator Decelerates Aging and Alzheimer’s Disease Progression in Caenorhabditis elegans and Neuronal Cultures. Antioxid Redox Signal. 2016 Dec 1;25(16):855-869.

Cell Assay ^[1]	For the determination of cell cycle, 5×10⁵ cells per well are seeded onto 6-well plates and incubated overnight in complete growth medium (DMEM+10% FBS). After starvation for 24 h, the cells are subsequently stimulated with 10% FBS with or without the presence of 18α-Glycyrrhetinic acid (18a-GA). The final concentration of 18α-Glycyrrhetinic acid is 8.0 mM. The cells are incubated for 24 h, 48 h and 72 h, respectively, and then the flow cytometric analysis is performed. Flow cytometric analysis is performed in triplicate. After being treated with 18α-Glycyrrhetinic acid, the cells are stained and then cell apoptosis status is measured by flow cytometry^[1]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Administration ^[2]	C. elegans strains are used in this study. Synchronized L4 larvae CL2006 animals (100 to 120 animals per condition) are transferred to nematode growth medium (NGM) plates containing either 18α-Glycyrrhetinic acid (18α-GA) or DMSO at 20°C. Synchronized CL4176 animals (150 to 300 animals per condition) are transferred to NGM plates containing either 18α-Glycyrrhetinic acid or DMSO at 16°C for 48 h before temperature upshift to 25°C for transgene induction. Scoring of paralyzed animals is initiated at day 1 of adulthood for CL2006 strain and 24 h after temperature upshift for CL4176 strain. Each paralysis assay is repeated at least thrice. Nematodes are scored as paralyzed if they exhibit halos of cleared bacteria around their heads or fail to undergo half end body wave propagation upon prodding^[2]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.
参考文献	[1]. Zong L et al. 18α-glycyrrhetinic acid extracted from Glycyrrhiza radix inhibits proliferation and promotes apoptosis of the hepatic stellate cell line. J Dig Dis. 2013 Jun;14(6):328-36. [2]. Papaevgeniou N, et al. 18α-Glycyrrhetinic Acid Proteasome Activator Decelerates Aging and Alzheimer’s Disease Progression in Caenorhabditis elegans and Neuronal Cultures. Antioxid Redox Signal. 2016 Dec 1;25(16):855-869.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

Butyric acid-d7(Synonyms: Butanoic acid-d7)

发表于2024年4月11日由上海金畔生物科技有限公司

Butyric acid-d7 (Synonyms: Butanoic acid-d7)

Butyric acid-d7 (Butanoic acid-d7) 是 Butyric acid 的氘代物。Butyric acid 是一种 HDAC 抑制剂，具有抗肿瘤活性。

Butyric acid-d7 Chemical Structure

CAS No. : 73607-83-7

规格	价格	是否有货
10 mg	￥900	询问价格 & 货期
25 mg	￥1900	询问价格 & 货期
50 mg	￥3000	询问价格 & 货期

* Please select Quantity before adding items.

生物活性	Butyric acid-d7 (Butanoic acid-d7) is the deuterium labeled Butyric acid. Butyric acid is a histone deacetylase (HDAC) inhibitor, with anti-tumor effects in several cancers.
体外研究 (In Vitro)	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs^[1]. Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
分子量	95.15
Formula	C₄HD₇O₂
CAS 号	73607-83-7
运输条件	Room temperature in continental US; may vary elsewhere.
储存方式	Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Wang P, et al. Sodium butyrate triggers a functional elongation of microglial process via Akt-small RhoGTPase activation and HDACs inhibition. Neurobiol Dis. 2018 Mar;111:12-25.;Huang W, et al. Inhibition of store-operated Ca2+ entry counteracts the apoptosis of nasopharyngeal carcinoma cells induced by sodium butyrate. Oncol Lett. 2017 Feb;13(2):921-929.;Jaworska J, et al. The potential neuroprotective role of a histone deacetylase inhibitor, sodium butyrate, after neonatal hypoxia-ischemia. J Neuroinflammation. 2017 Feb 10;14(1):34.;Qiu Y, et al. Effect of sodium butyrate on cell proliferation and cell cycle in porcine intestinal epithelial (IPEC-J2) cells. In Vitro Cell Dev Biol Anim. 2017 Jan 27.;Jung HY, et al. Sirtuin-2 inhibition affects hippocampal functions and sodium butyrate ameliorates the reduction in novel object memory, cell proliferation, and neuroblast differentiation. Lab Anim Res. 2016 Dec;32(4):224-230.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

Methylmalonic acid-d3(Synonyms: Methylpropanedioic acid-d3; Methylmalonate-d3)

发表于2024年4月11日由上海金畔生物科技有限公司

Methylmalonic acid-d3 (Synonyms: Methylpropanedioic acid-d3; Methylmalonate-d3)

Methylmalonic acid-d3 (Methylpropanedioic acid-d3) 是 Methylmalonic acid 的氘代物。Methylmalonic acid (Methylmalonate) 是癌症患者维生素 B-12 缺乏的指标。

Methylmalonic acid-d3 Chemical Structure

CAS No. : 42522-59-8

规格	价格	是否有货
5 mg	￥900	询问价格 & 货期
10 mg	￥1500	询问价格 & 货期
25 mg	￥3400	询问价格 & 货期

* Please select Quantity before adding items.

生物活性	Methylmalonic acid-d3 (Methylpropanedioic acid-d3) is the deuterium labeled Methylmalonic acid. Methylmalonic acid (Methylmalonate) is an indicator of Vitamin B-12 deficiency in cancer^[1]^[2].
体外研究 (In Vitro)	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs^[1]. Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
分子量	121.11
Formula	C₄H₃D₃O₄
CAS 号	42522-59-8
运输条件	Room temperature in continental US; may vary elsewhere.
储存方式	Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Vashi P, et al. Methylmalonic Acid and Homocysteine as Indicators of Vitamin B-12 Deficiency in Cancer. PLoS One. 2016 Jan 25;11(1):e0147843.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

Oleanonic acid(Synonyms: 3-Oxooleanolic acid)

发表于2024年4月11日由上海金畔生物科技有限公司

Oleanonic acid (Synonyms: 3-Oxooleanolic acid) 纯度: ≥98.0%

Oleanonic acid (3-Oxooleanolic acid) 是一种三萜，可以抑制 HIV-1 对细胞的感染。起抑制 HIV-1 体外感染 PBMC，自然感染 PBMC和单核细胞/巨噬细胞的 EC₅₀ 分别为 22.7 mM，24.6 mM 和57.4 mM。除此之外，它可以抑制鼠腹腔白细胞产生白三烯 B4，IC₅₀为 17 μM。

Oleanonic acid Chemical Structure

CAS No. : 17990-42-0

规格	价格	是否有货
10 mM * 1 mL in DMSO	￥550	In-stock
50 mg	￥500	In-stock
100 mg		询价
200 mg		询价

* Please select Quantity before adding items.

Oleanonic acid 相关产品

•相关化合物库:

Natural Product Library Plus
Bioactive Compound Library Plus
Anti-Infection Compound Library
Natural Product Library
Anti-Cancer Compound Library
Antiviral Compound Library
Lipid Compound Library
Terpenoids Library
Traditional Chinese Medicine Monomer Library

生物活性

Oleanonic acid (3-Oxooleanolic acid) is a triterpenoid, inhibits infection by HIV-1 in in vitro infected PBMC, naturally infected PBMC and monocyte/macrophages with EC₅₀ of 22.7 mM, 24.6 mM and 57.4 mM, respectively.

分子量

454.68

Formula

C₃₀H₄₆O₃

CAS 号

17990-42-0

中文名称

齐墩果酮酸

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

溶解性数据

In Vitro:

DMSO : 100 mg/mL (219.93 mM; Need ultrasonic)

H₂O : < 0.1 mg/mL (insoluble)

配制储备液

浓度溶剂体积质量	1 mg	5 mg	10 mg

1 mM	2.1993 mL	10.9967 mL	21.9935 mL
5 mM	0.4399 mL	2.1993 mL	4.3987 mL
10 mM	0.2199 mL	1.0997 mL	2.1993 mL

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液，再依次添加助溶剂：

1.

请依序添加每种溶剂： 10% DMSO 40% PEG300 5% Tween-80 45% saline

Solubility: ≥ 2.5 mg/mL (5.50 mM); Clear solution

此方案可获得 ≥ 2.5 mg/mL (5.50 mM，饱和度未知) 的澄清溶液。

以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中，混合均匀；向上述体系中加入50 μL Tween-80，混合均匀；然后继续加入 450 μL生理盐水定容至 1 mL。

将 0.9 g 氯化钠，完全溶解于 100 mL ddH₂O 中，得到澄清透明的生理盐水溶液
2.

请依序添加每种溶剂： 10% DMSO 90% (20% SBE-β-CD in saline)

Solubility: 2.5 mg/mL (5.50 mM); Suspended solution; Need ultrasonic

此方案可获得 2.5 mg/mL (5.50 mM) 的均匀悬浊液，悬浊液可用于口服和腹腔注射。

以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中，混合均匀。

将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中，再用生理盐水定容至 10 mL，完全溶解，澄清透明
3.

请依序添加每种溶剂： 10% DMSO 90% corn oil

Solubility: ≥ 2.5 mg/mL (5.50 mM); Clear solution

此方案可获得 ≥ 2.5 mg/mL (5.50 mM，饱和度未知) 的澄清溶液，此方案不适用于实验周期在半个月以上的实验。

以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中，混合均匀。

*以上所有助溶剂都可在上海金畔生物科技有限公司网站选购。

参考文献

[1]. Giner-Larza EM et al.Oleanonic acid, a 3-oxotriterpene from Pistacia, inhibits leukotriene synthesis and has anti-inflammatory activity.Eur J Pharmacol.Sep 28;428(1):137-43.doi:10.1016/S0014-2999(01)01290-0(2001)

[2]. Fabio Mengoni.Anti-HIV Activity of Oleanolic Acid on Infected Human Mononuclear Cells.Planta Med 68(2): 111-114.DOI: 10.1055/s-2002-20256(2002)

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

Stearic acid(Synonyms: 硬脂酸)

发表于2024年4月11日由上海金畔生物科技有限公司

Stearic acid (Synonyms: 硬脂酸) 纯度: ≥98.0%

Stearic acid是一种长链膳食饱和脂肪酸，存在于许多动植物油脂中。

Stearic acid Chemical Structure

CAS No. : 57-11-4

规格	价格	是否有货
10 mM * 1 mL in DMSO	￥500	In-stock
500 mg	￥400	In-stock
1 g	￥500	In-stock
5 g		询价
10 g		询价

* Please select Quantity before adding items.

Stearic acid 相关产品

•相关化合物库:

Natural Product Library Plus
Drug Repurposing Compound Library Plus
FDA-Approved Drug Library Plus
Bioactive Compound Library Plus
Metabolism/Protease Compound Library
Natural Product Library
FDA-Approved Drug Library
Anti-Cancer Compound Library
Human Endogenous Metabolite Compound Library
Drug Repurposing Compound Library
Lipid Compound Library
Medicine Food Homology Compound Library
Traditional Chinese Medicine Monomer Library
FDA Approved & Pharmacopeial Drug Library
Gut Microbial Metabolite Library
Microbial Metabolite Library
Food Additive Library
Food-Sourced Compound Library
Inactive Ingredient Library

生物活性

Stearic acid is a long chain dietary saturated fatty acid which exists in many animal and vegetable fats and oils.

IC₅₀ & Target

Human Endogenous Metabolite

Clinical Trial

分子量

284.48

Formula

C₁₈H₃₆O₂

CAS 号

57-11-4

中文名称

硬脂酸；硬脂肪酸；硬酯酸；十八烷酸

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

溶解性数据

In Vitro:

DMSO : 125 mg/mL (439.40 mM; Need ultrasonic)

配制储备液

浓度溶剂体积质量	1 mg	5 mg	10 mg

1 mM	3.5152 mL	17.5759 mL	35.1519 mL
5 mM	0.7030 mL	3.5152 mL	7.0304 mL
10 mM	0.3515 mL	1.7576 mL	3.5152 mL

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液，再依次添加助溶剂：

1.

请依序添加每种溶剂： 10% DMSO 40% PEG300 5% Tween-80 45% saline

Solubility: 2.08 mg/mL (7.31 mM); Suspended solution; Need ultrasonic

此方案可获得 2.08 mg/mL (7.31 mM) 的均匀悬浊液，悬浊液可用于口服和腹腔注射。

以 1 mL 工作液为例，取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中，混合均匀；向上述体系中加入50 μL Tween-80，混合均匀；然后继续加入 450 μL生理盐水定容至 1 mL。

将 0.9 g 氯化钠，完全溶解于 100 mL ddH₂O 中，得到澄清透明的生理盐水溶液
2.

请依序添加每种溶剂： 10% DMSO 90% (20% SBE-β-CD in saline)

Solubility: 2.08 mg/mL (7.31 mM); Suspended solution; Need ultrasonic

此方案可获得 2.08 mg/mL (7.31 mM) 的均匀悬浊液，悬浊液可用于口服和腹腔注射。

以 1 mL 工作液为例，取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中，混合均匀。

将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中，再用生理盐水定容至 10 mL，完全溶解，澄清透明
3.

请依序添加每种溶剂： 10% DMSO 90% corn oil

Solubility: ≥ 2.08 mg/mL (7.31 mM); Clear solution

此方案可获得 ≥ 2.08 mg/mL (7.31 mM，饱和度未知) 的澄清溶液，此方案不适用于实验周期在半个月以上的实验。

以 1 mL 工作液为例，取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中，混合均匀。

*以上所有助溶剂都可在上海金畔生物科技有限公司网站选购。

参考文献

[1]. Shen MC et al. Dietary stearic acid leads to a reduction of visceral adipose tissue in athymic nude mice. PLoS One. 2014 Sep 15;9(9):e104083.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

Salvianolic acid C(Synonyms: 丹酚酸 C)

发表于2024年4月11日由上海金畔生物科技有限公司

Salvianolic acid C (Synonyms: 丹酚酸 C) 纯度: 99.94%

Salvianolic acid C 是细胞色素 P4502C8 (CYP2C8) 的非竞争性抑制剂和细胞色素 P4502J2 (CYP2J2) 中等强度的混合抑制剂，其对 CYP2C8 和 CYP2J2 的 K_i 值分别为 4.82 μM 和 5.75 μM。

Salvianolic acid C Chemical Structure

CAS No. : 115841-09-3

规格	价格	是否有货
10 mM * 1 mL in DMSO	￥1210	In-stock
5 mg	￥1100	In-stock
10 mg	￥1750	In-stock
25 mg	￥3750	In-stock
50 mg		询价
100 mg		询价

* Please select Quantity before adding items.

Salvianolic acid C 相关产品

•相关化合物库:

Natural Product Library Plus
Bioactive Compound Library Plus
Metabolism/Protease Compound Library
Natural Product Library
Anti-Cancer Compound Library
Anti-Aging Compound Library
Antioxidants Compound Library
Oxygen Sensing Compound Library
Phenols Library
Pyroptosis Compound Library
Traditional Chinese Medicine Monomer Library
Targeted Diversity Library

生物活性

Salvianolic acid C is a noncompetitive Cytochrome P4502C8 (CYP2C8) inhibitor and a moderate mixed inhibitor of Cytochrome P45022J2 (CYP2J2), with K_is of 4.82 μM and 5.75 μM for CYP2C8 and CYP2J2, respectively.

IC₅₀ & Target

CYP2C8

4.82 μM (Ki)

CYP2J2

5.75 μM (Ki)

体外研究
(In Vitro)

Salvianolic acid C is a noncompetitive CYP2C8 inhibitor and a moderate mixed inhibitor of CYP2J2, with K_is of 4.82, 5.75 μM for CYP2C8 and CYP2J2, respectively^[1]. 1 and 5 μM Salvianolic acid C (SalC) could significantly inhibit the NO production induced by LPS. Salvianolic acid C decreases the expression of iNOS significantly. Salvianolic acid C inhibits LPS-induced TNF-α, IL-1β, IL-6 and IL-10 overproduction. Salvianolic acid C inhibits LPS-induced NF‑κB activation. Salvianolic acid C also increases the expression of Nrf2 and HO-1 in BV2 microglial cells^[2].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

Salvianolic acid C (20 mg/kg) treatment could significantly decrease the escape latency. In addition, SalC (10 and 20 mg/kg) treatment significantly increase the platform crossing number compared with the LPS model group. Systemic administration of Salvianolic acid C down regulates the brain TNF-α, IL-1β and IL-6 levels compared with the model group. The iNOS and COX-2 levels in rat brain cortex and hippocampus are higher than that in the control group, while Salvianolic acid C treatment significantly down regulates the cortex and hippocampus regions. Salvianolic acid C (5, 10 and 20 mg/kg) treatment dose-dependently increases the p-AMPK, Nrf2, HO-1 and NQO1 levels in rat brain cortex and hippocampus^[2].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

492.43

Formula

C₂₆H₂₀O₁₀

CAS 号

115841-09-3

中文名称

丹酚酸 C

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moisture and light

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

溶解性数据

In Vitro:

DMSO : 50 mg/mL (101.54 mM; Need ultrasonic)

配制储备液

浓度溶剂体积质量	1 mg	5 mg	10 mg

1 mM	2.0307 mL	10.1537 mL	20.3075 mL
5 mM	0.4061 mL	2.0307 mL	4.0615 mL
10 mM	0.2031 mL	1.0154 mL	2.0307 mL

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)。-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液，再依次添加助溶剂：

1.

请依序添加每种溶剂： 10% DMSO 40% PEG300 5% Tween-80 45% saline

Solubility: ≥ 2.5 mg/mL (5.08 mM); Clear solution

此方案可获得 ≥ 2.5 mg/mL (5.08 mM，饱和度未知) 的澄清溶液。

以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中，混合均匀；向上述体系中加入50 μL Tween-80，混合均匀；然后继续加入 450 μL生理盐水定容至 1 mL。

将 0.9 g 氯化钠，完全溶解于 100 mL ddH₂O 中，得到澄清透明的生理盐水溶液
2.

请依序添加每种溶剂： 10% DMSO 90% (20% SBE-β-CD in saline)

Solubility: ≥ 2.5 mg/mL (5.08 mM); Clear solution

此方案可获得 ≥ 2.5 mg/mL (5.08 mM，饱和度未知) 的澄清溶液。

以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中，混合均匀。

将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中，再用生理盐水定容至 10 mL，完全溶解，澄清透明

*以上所有助溶剂都可在上海金畔生物科技有限公司网站选购。

参考文献

[1]. Xu MJ, et al. Inhibitory Effects of Danshen components on CYP2C8 and CYP2J2. Chem Biol Interact. 2018 Jun 1;289:15-22.

[2]. Song J, et al. Activation of Nrf2 signaling by salvianolic acid C attenuates NF‑κB mediated inflammatory response both in vivo and in vitro. Int Immunopharmacol. 2018 Oct;63:299-310.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

Pomalidomide 4′-PEG5-acid(Synonyms: Pomalidomide-PEG5-CO2H)

发表于2024年4月11日由上海金畔生物科技有限公司

Pomalidomide 4′-PEG5-acid (Synonyms: Pomalidomide-PEG5-CO2H) 纯度: 95.02%

Pomalidomide 4′-PEG5-acid (Pomalidomide-PEG5-CO2H) 是一种合成的 E3 连接酶配体-linker 偶联物 (E3 ligase ligand-linker conjugate)，包含基于 Pomalidomide 的 cereblon 配体和 5 个单元 PEG 的 linker。

Pomalidomide 4′-PEG5-acid Chemical Structure

CAS No. : 2139348-63-1

规格	价格	是否有货
50 mg	￥4000	In-stock
100 mg	￥6500	In-stock
200 mg		询价
500 mg		询价

* Please select Quantity before adding items.

生物活性

Pomalidomide 4′-PEG5-acid (Pomalidomide-PEG5-CO2H) is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and 5-unit PEG linker used in PROTAC technology^[1].

IC₅₀ & Target^[1]

Cereblon

体外研究
(In Vitro)

PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins^[1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

565.57

Formula

C₂₆H₃₅N₃O₁₁

CAS 号

2139348-63-1

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

-20°C, stored under nitrogen

*In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)

参考文献

[1]. [1]Jing Liu, et al. Cyclic-amp response element binding protein (cbp) and/or adenoviral e1a binding protein of 300 kda (p300) degradation compounds and methods of use. WO2020173440A1.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

Ursodeoxycholic acid-d5(Synonyms: Ursodiol-d5; UDCA-d5)

发表于2024年4月10日由上海金畔生物科技有限公司

Ursodeoxycholic acid-d5 (Synonyms: Ursodiol-d5; UDCA-d5)

Ursodeoxycholic acid-d5 (Ursodiol-d5) 是 Ursodeoxycholic acid 的氘代物。Ursodeoxycholic acid (Ursodeoxycholate) 是由肠道细菌转化 (cheno)脱氧胆酸而产生的一种次级胆汁酸，是肠道屏障完整性的关键调节因子，对脂质代谢至关重要。Ursodeoxycholic acid 作为信号分子，通过与胆汁酸激活的受体相互作用发挥作用，包括G蛋白偶联的胆汁酸受体5 (TGR5，GPCR19) 和法尼酯X受体 (FXR)。Ursodeoxycholic acid 可用于多种肝脏和胃肠道疾病的研究。具有口服活性。

Ursodeoxycholic acid-d5 Chemical Structure

CAS No. : 93701-18-9

规格		是否有货
2.5 mg		Check price and availability
1 mg		Check price and availability
5 mg		Check price and availability
10 mg		Check price and availability

* Please select Quantity before adding items.

生物活性	Ursodeoxycholic acid-d5 (Ursodiol-d5) is the deuterium labeled Ursodeoxycholic acid. Ursodeoxycholic acid (Ursodeoxycholate) is a secondary bile acid issued from the transformation of (cheno)deoxycholic acid by intestinal bacteria, acting as a key regulator of the intestinal barrier integrity and essential for lipid metabolism. Ursodeoxycholic acid acts as signaling molecule, exerting its effects by interacting with bile acid activated receptors, including G-protein coupled bile acid receptor 5 (TGR5, GPCR19) and the farnesoid X receptor (FXR). Ursodeoxycholic acid can be used for the research of a variety of hepatic and gastrointestinal diseases. Orally active^[1]^[2].
体外研究 (In Vitro)	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs^[1]. Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
分子量	397.60
Formula	C₂₄H₃₅D₅O₄
CAS 号	93701-18-9
中文名称	熊去氧胆酸 d5
运输条件	Room temperature in continental US; may vary elsewhere.
储存方式	Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Jackson H, et al. Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: a population-based cohort study. Hepatology. 2007 Oct;46(4):1131-7. [3]. Kumar D, et al. Use of ursodeoxycholic acid in liver diseases. J Gastroenterol Hepatol. 2001 Jan;16(1):3-14. [4]. Biao Nie, et al. Specific Bile Acids Inhibit Hepatic Fatty Acid Uptake in Mice. Hepatology. 2012 Oct;56(4):1300-10.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

Cy3 PEG acid, Cy3-PEG-COOH Cat. No. PG2-CAS3-5k 5000 Da 5 mg修饰性聚乙二醇

发表于2024年4月9日由上海金畔生物科技有限公司

上海金畔生物科技有限公司提供各种分子量和基团修饰性聚乙二醇定制服务。

Cy3 PEG acid, Cy3-PEG-COOH

Cat. No.	PG2-CAS3-5k
Specification	5000 Da
Unit Size	5 mg
Price	$325.00

Description:

Cy3 labeled polyethylene glycol is a near infrared fluorescent PEG derivative that has a maximum absorption at 550 nm and emission around 570 nm. Cy3 labeled PEG derivative can be easily traced from its blue color and strong fluorescence. Additional functionality allows these fluorescent PEG derivatives to be easily conjugated to other molecule or material surfaces.

Physical Properties:

Pink or pink purple solid or viscous liquid depends on molecule weight;
Soluble in regular aqeous solution as well as most organic solvents;

Storage Conditions:

Store at -20 ⁰C, dessiccated Protect from light. Avoid frequent thaw and freeze.

Documents

SDS
DataSheet

生物活性分子抑制剂Asiatic acid

发表于2024年4月9日由上海金畔生物科技有限公司

Asiatic acid 纯度: 99.47%

Asiatic acid，是在 Centella asiatica 中发现的一种五环三萜，可诱导黑色素瘤细胞的凋亡，有用于皮肤癌的潜能。Asiatic acid 还拥有抗炎活性。

Asiatic acid Chemical Structure

CAS No. : 464-92-6

规格	价格	是否有货
Free Sample (0.1-0.5 mg)		Apply now
10 mM * 1 mL in DMSO	￥550	In-stock
10 mg	￥500	In-stock
50 mg	￥1500	In-stock
100 mg	￥2500	In-stock
200 mg		询价
500 mg		询价

* Please select Quantity before adding items.

Asiatic acid 相关产品

•相关化合物库:

Natural Product Library Plus
Bioactive Compound Library Plus
Anti-Infection Compound Library
Apoptosis Compound Library
Immunology/Inflammation Compound Library
Natural Product Library
Anti-Cancer Compound Library
Lipid Compound Library
Terpenoids Library
Traditional Chinese Medicine Monomer Library
FDA Approved & Pharmacopeial Drug Library
Antiparasitic Compound library
Food-Sourced Compound Library

生物活性

Asiatic acid, a pentacyclic triterpene found in Centella asiatica, induces apoptosis in melanoma cells. Asiatic acid has the potential for skin cancer treatment^[1]. Asiatic acid also has anti-inflammatory activities^[2].

分子量

488.70

Formula

C₃₀H₄₈O₅

CAS 号

464-92-6

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

溶解性数据

In Vitro:

DMSO : 250 mg/mL (511.56 mM; Need ultrasonic)

配制储备液

浓度溶剂体积质量	1 mg	5 mg	10 mg

1 mM	2.0462 mL	10.2312 mL	20.4625 mL
5 mM	0.4092 mL	2.0462 mL	4.0925 mL
10 mM	0.2046 mL	1.0231 mL	2.0462 mL

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液，再依次添加助溶剂：

1.

请依序添加每种溶剂： 10% DMSO 40% PEG300 5% Tween-80 45% saline

Solubility: ≥ 2.25 mg/mL (4.60 mM); Clear solution

此方案可获得 ≥ 2.25 mg/mL (4.60 mM，饱和度未知) 的澄清溶液。

以 1 mL 工作液为例，取 100 μL 22.5 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中，混合均匀；向上述体系中加入50 μL Tween-80，混合均匀；然后继续加入 450 μL生理盐水定容至 1 mL。

将 0.9 g 氯化钠，完全溶解于 100 mL ddH₂O 中，得到澄清透明的生理盐水溶液
2.

请依序添加每种溶剂： 10% DMSO 90% (20% SBE-β-CD in saline)

Solubility: 2.08 mg/mL (4.26 mM); Suspended solution; Need ultrasonic

此方案可获得 2.08 mg/mL (4.26 mM) 的均匀悬浊液，悬浊液可用于口服和腹腔注射。

以 1 mL 工作液为例，取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中，混合均匀。

将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中，再用生理盐水定容至 10 mL，完全溶解，澄清透明
3.

请依序添加每种溶剂： 10% DMSO 90% corn oil

Solubility: ≥ 2.08 mg/mL (4.26 mM); Clear solution

此方案可获得 ≥ 2.08 mg/mL (4.26 mM，饱和度未知) 的澄清溶液，此方案不适用于实验周期在半个月以上的实验。

以 1 mL 工作液为例，取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中，混合均匀。

*以上所有助溶剂都可在上海金畔生物科技有限公司网站选购。

参考文献

[1]. Park BC, et al. Asiatic acid induces apoptosis in SK-MEL-2 human melanoma cells. Cancer Lett. 2005 Jan 31;218(1):81-90.

[2]. Huang SS, et al. Antinociceptive activities and the mechanisms of anti-inflammation of asiatic Acid in mice. Evid Based Complement Alternat Med. 2011;2011:895857.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

生物活性分子抑制剂Asiatic acid

发表于2024年4月9日由上海金畔生物科技有限公司

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。
Asiatic acid 纯度: 99.47%

Asiatic acid，是在 Centella asiatica 中发现的一种五环三萜，可诱导黑色素瘤细胞的凋亡，有用于皮肤癌的潜能。Asiatic acid 还拥有抗炎活性。

Asiatic acid Chemical Structure

CAS No. : 464-92-6

规格	价格	是否有货
Free Sample (0.1-0.5 mg)		Apply now
10 mM * 1 mL in DMSO	￥550	In-stock
10 mg	￥500	In-stock
50 mg	￥1500	In-stock
100 mg	￥2500	In-stock
200 mg		询价
500 mg		询价

* Please select Quantity before adding items.

Asiatic acid 相关产品

•相关化合物库:

Natural Product Library Plus
Bioactive Compound Library Plus
Anti-Infection Compound Library
Apoptosis Compound Library
Immunology/Inflammation Compound Library
Natural Product Library
Anti-Cancer Compound Library
Lipid Compound Library
Terpenoids Library
Traditional Chinese Medicine Monomer Library
FDA Approved & Pharmacopeial Drug Library
Antiparasitic Compound library
Food-Sourced Compound Library

生物活性

分子量

488.70

Formula

C₃₀H₄₈O₅

CAS 号

464-92-6

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

溶解性数据

In Vitro:

DMSO : 250 mg/mL (511.56 mM; Need ultrasonic)

配制储备液

浓度溶剂体积质量	1 mg	5 mg	10 mg

1 mM	2.0462 mL	10.2312 mL	20.4625 mL
5 mM	0.4092 mL	2.0462 mL	4.0925 mL
10 mM	0.2046 mL	1.0231 mL	2.0462 mL

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液，再依次添加助溶剂：

1.

请依序添加每种溶剂： 10% DMSO 40% PEG300 5% Tween-80 45% saline

Solubility: ≥ 2.25 mg/mL (4.60 mM); Clear solution

此方案可获得 ≥ 2.25 mg/mL (4.60 mM，饱和度未知) 的澄清溶液。

以 1 mL 工作液为例，取 100 μL 22.5 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中，混合均匀；向上述体系中加入50 μL Tween-80，混合均匀；然后继续加入 450 μL生理盐水定容至 1 mL。

将 0.9 g 氯化钠，完全溶解于 100 mL ddH₂O 中，得到澄清透明的生理盐水溶液
2.

请依序添加每种溶剂： 10% DMSO 90% (20% SBE-β-CD in saline)

Solubility: 2.08 mg/mL (4.26 mM); Suspended solution; Need ultrasonic

此方案可获得 2.08 mg/mL (4.26 mM) 的均匀悬浊液，悬浊液可用于口服和腹腔注射。

以 1 mL 工作液为例，取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中，混合均匀。

将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中，再用生理盐水定容至 10 mL，完全溶解，澄清透明
3.

请依序添加每种溶剂： 10% DMSO 90% corn oil

Solubility: ≥ 2.08 mg/mL (4.26 mM); Clear solution

此方案可获得 ≥ 2.08 mg/mL (4.26 mM，饱和度未知) 的澄清溶液，此方案不适用于实验周期在半个月以上的实验。

以 1 mL 工作液为例，取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中，混合均匀。

*以上所有助溶剂都可在上海金畔生物科技有限公司网站选购。

参考文献

[1]. Park BC, et al. Asiatic acid induces apoptosis in SK-MEL-2 human melanoma cells. Cancer Lett. 2005 Jan 31;218(1):81-90.

[2]. Huang SS, et al. Antinociceptive activities and the mechanisms of anti-inflammation of asiatic Acid in mice. Evid Based Complement Alternat Med. 2011;2011:895857.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

Lipoic acid PEG Maleimide, LA-PEG-Mal Cat. No. PG2-LAML-3k 3400 Da 50 mg修饰性聚乙二醇

发表于2024年4月9日由上海金畔生物科技有限公司

上海金畔生物科技有限公司提供各种分子量和基团修饰性聚乙二醇定制服务。

Lipoic acid PEG Maleimide, LA-PEG-Mal

Cat. No.	PG2-LAML-3k
Specification	3400 Da
Unit Size	50 mg
Price	$325.00

Description:

Lipoic acid, also known as thioctic acid, is an important bioactive molecule participating in various biological processes. PEG functionalized lipoic acid can be used to bind to metallic particle or film surface with its -S-S-bond. Lipoic acid group has high affinity to metallic surfaces and have been widely used for gold nanoparticles and quantum dots surfaces. PEGylated lipoic acid is water soluble and can be used directly in aqueous buffer.

Physical Properties:

Off-yellow solid or viscous liquid depends on molecule weight;
Soluble in regular aqeous solution as well as most organic solvents;

Storage Conditions:

Store at -20 ⁰C, dessiccated Protect from light. Avoid frequent thaw and freeze.

Documents

SDS
DataSheet

生物活性分子抑制剂Citric acid(Synonyms: 柠檬酸)

发表于2024年4月9日由上海金畔生物科技有限公司

Citric acid (Synonyms: 柠檬酸) 纯度: ≥98.0%

Citric acid 是柑橘类水果中发现的弱有机三羧酸。柠檬酸是天然防腐剂和食品添加剂。

Citric acid Chemical Structure

CAS No. : 77-92-9

规格	价格	是否有货
10 mM * 1 mL in DMSO	￥550	In-stock
100 mg	￥500	In-stock
200 mg		询价
500 mg		询价

* Please select Quantity before adding items.

Citric acid 相关产品

•相关化合物库:

Natural Product Library Plus
Drug Repurposing Compound Library Plus
FDA-Approved Drug Library Plus
FDA-Approved Drug Library Mini
Bioactive Compound Library Plus
Anti-Infection Compound Library
Apoptosis Compound Library
Immunology/Inflammation Compound Library
Metabolism/Protease Compound Library
Natural Product Library
FDA-Approved Drug Library
Anti-Cancer Compound Library
Human Endogenous Metabolite Compound Library
Drug Repurposing Compound Library
Diabetes Related Compound Library
Anti-Cardiovascular Disease Compound Library
Antibacterial Compound Library
Ferroptosis Compound Library
Anti-COVID-19 Compound Library
NMPA-Approved Drug Library
Medicine Food Homology Compound Library
Orally Active Compound Library
Traditional Chinese Medicine Monomer Library
FDA Approved & Pharmacopeial Drug Library
Antibiotics Library
Food Additive Library
Food-Sourced Compound Library
Inactive Ingredient Library
Rare Diseases Drug Library

生物活性

Citric acid is a weak organic tricarboxylic acid found in citrus fruits. Citric acid is a natural preservative and food tartness enhancer.

IC₅₀ & Target

Human Endogenous Metabolite

体外研究
(In Vitro)

Citric acid induces apoptosis through the mitochondrial pathway in the human keratinocyte cell line HaCaT. It inhibits proliferation of HaCaT cells in a dose-dependent manner, but also induces apoptosis and cell cycle-arrest at the G2/M phase (before 24 h) and S phase (after 24 h)^[1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

Citric acid is found in all animal tissues as an intermediary substance in oxidative metabolism. The administration of citric acid (1–2 g/kg) attenuates LPS-induced elevations in brain MDA, nitrite, TNF-α, GPx, and PON1 activity. In the liver, nitrite is decreased by 1 g/kg citric acid. Citric acid (1-2 g/kg) decreases brain lipid peroxidation and inflammation, liver damage, and DNA fragmentation^[2]. Citric acid supplementation increases intestinal calcium and phosphorus absorption and the retention/intake ratio only in rats fed the 1% Ca diet. Citric acidsupplementation together with a calcium-rich diet allows to obtain an increased retention of calcium and phosphorus in bone. The prolonged administration of calcium citrate supplements may therefore help to increase bone mineral concentration^[3]. Oral administration of citric acid ameliorates ketosis and protects against the development of diabetic complications in an animal model of type 1 diabetes^[4].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Clinical Trial

分子量

192.12

Formula

C₆H₈O₇

CAS 号

77-92-9

中文名称

柠檬酸

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

溶解性数据

In Vitro:

H₂O : 100 mg/mL (520.51 mM; Need ultrasonic)

DMSO : 100 mg/mL (520.51 mM; Need ultrasonic)

配制储备液

浓度溶剂体积质量	1 mg	5 mg	10 mg

1 mM	5.2051 mL	26.0254 mL	52.0508 mL
5 mM	1.0410 mL	5.2051 mL	10.4102 mL
10 mM	0.5205 mL	2.6025 mL	5.2051 mL

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液，再依次添加助溶剂：

1.

请依序添加每种溶剂： 10% DMSO 40% PEG300 5% Tween-80 45% saline

Solubility: ≥ 2.5 mg/mL (13.01 mM); Clear solution

此方案可获得 ≥ 2.5 mg/mL (13.01 mM，饱和度未知) 的澄清溶液。

以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中，混合均匀；向上述体系中加入50 μL Tween-80，混合均匀；然后继续加入 450 μL生理盐水定容至 1 mL。

将 0.9 g 氯化钠，完全溶解于 100 mL ddH₂O 中，得到澄清透明的生理盐水溶液
2.

请依序添加每种溶剂： 10% DMSO 90% (20% SBE-β-CD in saline)

Solubility: ≥ 2.5 mg/mL (13.01 mM); Clear solution

此方案可获得 ≥ 2.5 mg/mL (13.01 mM，饱和度未知) 的澄清溶液。

以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中，混合均匀。

将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中，再用生理盐水定容至 10 mL，完全溶解，澄清透明
3.

请依序添加每种溶剂： 10% DMSO 90% corn oil

Solubility: ≥ 2.5 mg/mL (13.01 mM); Clear solution

此方案可获得 ≥ 2.5 mg/mL (13.01 mM，饱和度未知) 的澄清溶液，此方案不适用于实验周期在半个月以上的实验。

以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中，混合均匀。

*以上所有助溶剂都可在上海金畔生物科技有限公司网站选购。

参考文献

[1]. Ying TH, et al. Citric acid induces cell-cycle arrest and apoptosis of human immortalized keratinocyte cell line (HaCaT) via caspase- and mitochondrial-dependent signaling pathways. Anticancer Res. 2013 Oct;33(10):4411-20.

[2]. Abdel-Salam OM, et al. Citric acid effects on brain and liver oxidative stress in lipopolysaccharide-treated mice. J Med Food. 2014 May;17(5):588-98.

[3]. Lacour B, et al. Stimulation by citric acid of calcium and phosphorus bioavailability in rats fed a calcium-rich diet. Miner Electrolyte Metab. 1997;23(2):79-87.

[4]. Nagai R, et al. Citric acid inhibits development of cataracts, proteinuria and ketosis in streptozotocin (type 1) diabetic rats. Biochem Biophys Res Commun. 2010 Feb 26;393(1):118-22.

Cell Assay ^[1]	HaCaT cells are treated with different concentrations of citric acid (2.5, 5, 7.5, 10, 12.5 mM) for 24 h; 0.5% of DMSO (vehicle) is used as a control. Cells are then centrifuged at 1000 ×g for 5 min, and cell pellets are dissolved with 0.5 mL of Phosphate buffered saline (PBS) containing 5 μg/mL PI and viable cells are determined by using a flow cytometer for determination of viable cells^[1]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Administration ^[4]	Rats: Rats are induced of diabetes and divided randomly into an untreated diabetic group and two treated diabetic groups, receiving citric acid (2 g/L) in the drinking water, or insulin therapy. Insulin-treated rats receive 3 IU of neutral protamine Hagedorn insulin three times per week. Fasting (12 hr) blood samples are obtained from the tail vein two days after insulin injection for measurement of blood glucose, HbA1c and ketone bodies^[4]. ^[2]Mice: Citric acid is prepared in sterile physiological saline. Mice are randomly divided into five equal groups (six mice each). Mice are treated with either 0.2mL of: sterile physiological saline (group 1) or citric acid at doses of 1, 2, and 4 g/kg, orally (groups 2-4). Treatments are given just prior to endotoxin administration (LPS: 200 lg/kg, injected intraperitoneally, 0.1 mL). The fifth group received just the vehicle, no LPS (negative control). Mice are euthanized after 4 h of LPS or vehicle injection by decapitation under ether anesthesia, where the brain and liver of each mouse are then removed for analysis^[2]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.
参考文献	[1]. Ying TH, et al. Citric acid induces cell-cycle arrest and apoptosis of human immortalized keratinocyte cell line (HaCaT) via caspase- and mitochondrial-dependent signaling pathways. Anticancer Res. 2013 Oct;33(10):4411-20. [2]. Abdel-Salam OM, et al. Citric acid effects on brain and liver oxidative stress in lipopolysaccharide-treated mice. J Med Food. 2014 May;17(5):588-98. [3]. Lacour B, et al. Stimulation by citric acid of calcium and phosphorus bioavailability in rats fed a calcium-rich diet. Miner Electrolyte Metab. 1997;23(2):79-87. [4]. Nagai R, et al. Citric acid inhibits development of cataracts, proteinuria and ketosis in streptozotocin (type 1) diabetic rats. Biochem Biophys Res Commun. 2010 Feb 26;393(1):118-22.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

生物活性分子抑制剂Citric acid(Synonyms: 柠檬酸)

发表于2024年4月9日由上海金畔生物科技有限公司

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。
Citric acid (Synonyms: 柠檬酸) 纯度: ≥98.0%

Citric acid 是柑橘类水果中发现的弱有机三羧酸。柠檬酸是天然防腐剂和食品添加剂。

Citric acid Chemical Structure

CAS No. : 77-92-9

规格	价格	是否有货
10 mM * 1 mL in DMSO	￥550	In-stock
100 mg	￥500	In-stock
200 mg		询价
500 mg		询价

* Please select Quantity before adding items.

Citric acid 相关产品

•相关化合物库:

Natural Product Library Plus
Drug Repurposing Compound Library Plus
FDA-Approved Drug Library Plus
FDA-Approved Drug Library Mini
Bioactive Compound Library Plus
Anti-Infection Compound Library
Apoptosis Compound Library
Immunology/Inflammation Compound Library
Metabolism/Protease Compound Library
Natural Product Library
FDA-Approved Drug Library
Anti-Cancer Compound Library
Human Endogenous Metabolite Compound Library
Drug Repurposing Compound Library
Diabetes Related Compound Library
Anti-Cardiovascular Disease Compound Library
Antibacterial Compound Library
Ferroptosis Compound Library
Anti-COVID-19 Compound Library
NMPA-Approved Drug Library
Medicine Food Homology Compound Library
Orally Active Compound Library
Traditional Chinese Medicine Monomer Library
FDA Approved & Pharmacopeial Drug Library
Antibiotics Library
Food Additive Library
Food-Sourced Compound Library
Inactive Ingredient Library
Rare Diseases Drug Library

生物活性

Citric acid is a weak organic tricarboxylic acid found in citrus fruits. Citric acid is a natural preservative and food tartness enhancer.

IC₅₀ & Target

Human Endogenous Metabolite

体外研究
(In Vitro)

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Clinical Trial

分子量

192.12

Formula

C₆H₈O₇

CAS 号

77-92-9

中文名称

柠檬酸

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

溶解性数据

In Vitro:

H₂O : 100 mg/mL (520.51 mM; Need ultrasonic)

DMSO : 100 mg/mL (520.51 mM; Need ultrasonic)

配制储备液

浓度溶剂体积质量	1 mg	5 mg	10 mg

1 mM	5.2051 mL	26.0254 mL	52.0508 mL
5 mM	1.0410 mL	5.2051 mL	10.4102 mL
10 mM	0.5205 mL	2.6025 mL	5.2051 mL

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液，再依次添加助溶剂：

1.

请依序添加每种溶剂： 10% DMSO 40% PEG300 5% Tween-80 45% saline

Solubility: ≥ 2.5 mg/mL (13.01 mM); Clear solution

此方案可获得 ≥ 2.5 mg/mL (13.01 mM，饱和度未知) 的澄清溶液。

以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中，混合均匀；向上述体系中加入50 μL Tween-80，混合均匀；然后继续加入 450 μL生理盐水定容至 1 mL。

将 0.9 g 氯化钠，完全溶解于 100 mL ddH₂O 中，得到澄清透明的生理盐水溶液
2.

请依序添加每种溶剂： 10% DMSO 90% (20% SBE-β-CD in saline)

Solubility: ≥ 2.5 mg/mL (13.01 mM); Clear solution

此方案可获得 ≥ 2.5 mg/mL (13.01 mM，饱和度未知) 的澄清溶液。

以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中，混合均匀。

将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中，再用生理盐水定容至 10 mL，完全溶解，澄清透明
3.

请依序添加每种溶剂： 10% DMSO 90% corn oil

Solubility: ≥ 2.5 mg/mL (13.01 mM); Clear solution

此方案可获得 ≥ 2.5 mg/mL (13.01 mM，饱和度未知) 的澄清溶液，此方案不适用于实验周期在半个月以上的实验。

以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中，混合均匀。

*以上所有助溶剂都可在上海金畔生物科技有限公司网站选购。

参考文献

[1]. Ying TH, et al. Citric acid induces cell-cycle arrest and apoptosis of human immortalized keratinocyte cell line (HaCaT) via caspase- and mitochondrial-dependent signaling pathways. Anticancer Res. 2013 Oct;33(10):4411-20.

[2]. Abdel-Salam OM, et al. Citric acid effects on brain and liver oxidative stress in lipopolysaccharide-treated mice. J Med Food. 2014 May;17(5):588-98.

[3]. Lacour B, et al. Stimulation by citric acid of calcium and phosphorus bioavailability in rats fed a calcium-rich diet. Miner Electrolyte Metab. 1997;23(2):79-87.

[4]. Nagai R, et al. Citric acid inhibits development of cataracts, proteinuria and ketosis in streptozotocin (type 1) diabetic rats. Biochem Biophys Res Commun. 2010 Feb 26;393(1):118-22.

Cell Assay ^[1]	HaCaT cells are treated with different concentrations of citric acid (2.5, 5, 7.5, 10, 12.5 mM) for 24 h; 0.5% of DMSO (vehicle) is used as a control. Cells are then centrifuged at 1000 ×g for 5 min, and cell pellets are dissolved with 0.5 mL of Phosphate buffered saline (PBS) containing 5 μg/mL PI and viable cells are determined by using a flow cytometer for determination of viable cells^[1]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Administration ^[4]	Rats: Rats are induced of diabetes and divided randomly into an untreated diabetic group and two treated diabetic groups, receiving citric acid (2 g/L) in the drinking water, or insulin therapy. Insulin-treated rats receive 3 IU of neutral protamine Hagedorn insulin three times per week. Fasting (12 hr) blood samples are obtained from the tail vein two days after insulin injection for measurement of blood glucose, HbA1c and ketone bodies^[4]. ^[2]Mice: Citric acid is prepared in sterile physiological saline. Mice are randomly divided into five equal groups (six mice each). Mice are treated with either 0.2mL of: sterile physiological saline (group 1) or citric acid at doses of 1, 2, and 4 g/kg, orally (groups 2-4). Treatments are given just prior to endotoxin administration (LPS: 200 lg/kg, injected intraperitoneally, 0.1 mL). The fifth group received just the vehicle, no LPS (negative control). Mice are euthanized after 4 h of LPS or vehicle injection by decapitation under ether anesthesia, where the brain and liver of each mouse are then removed for analysis^[2]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.
参考文献	[1]. Ying TH, et al. Citric acid induces cell-cycle arrest and apoptosis of human immortalized keratinocyte cell line (HaCaT) via caspase- and mitochondrial-dependent signaling pathways. Anticancer Res. 2013 Oct;33(10):4411-20. [2]. Abdel-Salam OM, et al. Citric acid effects on brain and liver oxidative stress in lipopolysaccharide-treated mice. J Med Food. 2014 May;17(5):588-98. [3]. Lacour B, et al. Stimulation by citric acid of calcium and phosphorus bioavailability in rats fed a calcium-rich diet. Miner Electrolyte Metab. 1997;23(2):79-87. [4]. Nagai R, et al. Citric acid inhibits development of cataracts, proteinuria and ketosis in streptozotocin (type 1) diabetic rats. Biochem Biophys Res Commun. 2010 Feb 26;393(1):118-22.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务